CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02407249
NCT02407249N/ACompleted

Control for EU (European Union) Focal Impulse and Rotor Modulation Registry - Topera C-FIRM Registry-

Abbott Medical Devices·observational·Posted Apr 2, 2015·Updated Oct 16, 2019

In Brief

An observational study for Atrial Fibrillation. Completed, enrolled 73 participants across 9 sites in 2 countries.

Detailed Summary

This is a control registry to the E-FIRM registry to track conventional atrial fibrillation (AF) procedures in terms of clinical usage, handling, and the safety and effectiveness for the treatment of symptomatic atrial fibrillation. Conventional AF ablation is defined as pulmonary vein isolation (PVI) and any additional ablation for AF according to the standard routine of the center. Data items will be collected, if available, consistent and applicable with routine and standard clinical care at each participating site.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Netherlands
CollaboratorsI-Med-Pro GmbH

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2, 2015
Enrollment StartApr 1, 2015
Primary CompletionMay 31, 2017
Study CompletionJul 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.3 years ago